What is Survodutide?
Survodutide is a dual agonist of the GLP-1 and glucagon receptors under investigation for obesity and metabolic-associated fatty liver disease (MASH). It combines appetite regulation with effects on energy expenditure.
Also known as: BI 456906
Commonly researched for
Research status
Clinical trials — investigational.
Important considerations
Not approved. Investigational compound; use only under medical supervision.